RA Capital Management 13F holdings, Q4 2021
Holdings as of December 31, 2021 · filings on SEC EDGAR · latest filing →
RA Capital Management disclosed 97 US equity positions worth $5.7bn in its Q4 2021 13F filing. The largest position was ASND at 17.9% of the reported book, followed by NVAX and ITEOS THERAPEUTICS INC. Against the Q3 2021 filing, it opened 5 new positions, added to 7 and reduced 3 among the top 50 holdings.
What did RA Capital Management own in Q4 2021? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2021 |
|---|---|---|---|---|---|---|---|
| 1 | ASND ASCENDIS PHARMA A/S | Healthcare | 17.9% | $1.0bn | 7,567,900 | 2% | added |
| 2 | NVAX NOVAVAX INC | Healthcare | 5.3% | $300.1m | 2,097,794 | 0% | held |
| 3 | ITEOS THERAPEUTICS INC | 3.6% | $205.7m | 4,417,259 | 0% | held | |
| 4 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.1% | $174.3m | 5,614,428 | 0% | held |
| 5 | JANX JANUX THERAPEUTICS INC | Healthcare | 3.0% | $171.1m | 8,670,644 | 0% | held |
| 6 | CTKB CYTEK BIOSCIENCES INC | Healthcare | 2.8% | $156.8m | 9,607,028 | 0% | held |
| 7 | IMMUNOGEN INC | 2.6% | $150.2m | 20,241,458 | 10% | added | |
| 8 | CLYM ELIEM THERAPEUTICS INC | 2.4% | $137.6m | 13,150,849 | 0% | held | |
| 9 | ICOSAVAX INC | 2.3% | $132.2m | 5,779,347 | 0% | held | |
| 10 | DICE THERAPEUTICS INC | 2.3% | $131.8m | 5,208,911 | 0% | held | |
| 11 | VOR VOR BIOPHARMA INC | 2.3% | $129.2m | 11,120,973 | 0% | held | |
| 12 | FORMA THERAPEUTICS | 2.3% | $128.1m | 9,011,651 | 0% | held | |
| 13 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.8% | $101.8m | 7,236,454 | 0% | held |
| 14 | PCVX VAXCYTE INC | Healthcare | 1.8% | $100.9m | 4,240,464 | 9% | added |
| 15 | MGNX MACROGENICS INC | Healthcare | 1.7% | $98.0m | 6,103,594 | 3% | added |
| 16 | AEROVATE THERAPEUTICS INC | 1.7% | $97.4m | 8,263,982 | 0% | held | |
| 17 | NKTX NKARTA INC | Healthcare | 1.5% | $86.0m | 5,605,129 | 0% | held |
| 18 | DAWNGBX DAY ONE BIOPHARMACEUTICALS | 1.5% | $83.7m | 4,965,588 | 0% | held | |
| 19 | TIL INSTIL BIO INC | 1.5% | $83.3m | 4,870,793 | 0% | held | |
| 20 | BELLUS HEALTH INC NEW | 1.5% | $82.4m | 10,230,274 | – | new | |
| 21 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.2% | $69.7m | 1,804,795 | 13% | added |
| 22 | TNYA TENAYA THERAPEUTICS INC | 1.2% | $67.3m | 3,551,508 | 0% | held | |
| 23 | GHRS GH RESEARCH PLC | 1.2% | $66.3m | 2,843,757 | -6% | reduced | |
| 24 | ABOS ACUMEN PHARMACEUTICALS INC | 1.2% | $66.0m | 9,770,773 | 0% | held | |
| 25 | 89BIO INC | 1.1% | $64.9m | 4,965,769 | 0% | held | |
| 26 | KINNATE BIOPHARMA INC | 1.1% | $63.7m | 3,593,052 | 0% | held | |
| 27 | PHAT PHATHOM PHARMACEUTICALS INC | 1.1% | $61.3m | 3,115,008 | 0% | held | |
| 28 | MIRATI THERAPEUTICS INC | 1.0% | $55.9m | 381,046 | – | new | |
| 29 | ZOGENIX INC | 1.0% | $54.2m | 3,333,700 | 0% | held | |
| 30 | PARDES BIOSCIENCES INC | 0.9% | $51.2m | 3,127,038 | – | new | |
| 31 | HOWL WEREWOLF THERAPEUTICS INC | 0.9% | $51.1m | 4,291,881 | 0% | held | |
| 32 | POINT BIOPHARMA GLOBAL INC | 0.9% | $50.4m | 9,003,018 | 2% | added | |
| 33 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 0.9% | $48.6m | 4,871,067 | 0% | held |
| 34 | LIANY LIANBIO | 0.8% | $47.2m | 7,655,015 | – | new | |
| 35 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 0.8% | $46.8m | 2,186,636 | 0% | held |
| 36 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.8% | $46.0m | 2,107,149 | 0% | held |
| 37 | RLMD RELMADA THERAPEUTICS | Healthcare | 0.8% | $45.1m | 2,000,000 | – | new |
| 38 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.8% | $44.4m | 1,377,569 | 0% | held |
| 39 | TGTX TG THERAPEUTICS INC | Healthcare | 0.7% | $42.0m | 2,210,145 | -46% | reduced |
| 40 | EYPT EYEPOINT PHARMACEUTICALS | Healthcare | 0.7% | $41.3m | 3,370,506 | 52% | added |
| 41 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.7% | $40.3m | 3,577,094 | 0% | held | |
| 42 | EWTX EDGEWISE THERAPEUTICS INC | 0.7% | $39.9m | 2,613,623 | 0% | held | |
| 43 | PMVP PMV PHARMACEUTICALS INC | 0.7% | $39.5m | 1,710,265 | 0% | held | |
| 44 | CYTEIR THERAPEUTICS INC | 0.7% | $38.1m | 3,350,506 | 0% | held | |
| 45 | GERN GERON CORP | Healthcare | 0.6% | $36.8m | 30,126,299 | 0% | held |
| 46 | IVVD ADAGIO THERAPEUTICS INC | Healthcare | 0.6% | $36.3m | 4,995,807 | -6% | reduced |
| 47 | CNTB CONNECT BIOPHARMA HLDGS LTD | 0.6% | $36.0m | 6,991,003 | 0% | held | |
| 48 | RXST RXSIGHT INC | Healthcare | 0.6% | $34.3m | 3,052,796 | 0% | held |
| 49 | VRNA VERONA PHARMA PLC | 0.6% | $34.3m | 5,100,000 | 0% | held | |
| 50 | GRAPHITE BIO INC | 0.6% | $33.5m | 2,698,369 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.